These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15192465)

  • 21. Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1.
    Salamon J; Derlin T; Bannas P; Busch JD; Herrmann J; Bockhorn M; Hagel C; Friedrich RE; Adam G; Mautner VF
    Eur J Nucl Med Mol Imaging; 2013 May; 40(5):685-92. PubMed ID: 23232507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
    Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tc-99m MDP uptake in retroperitoneal malignant peripheral nerve sheath tumor and its metastases.
    Li L; Kuang A; Sheng S
    Clin Nucl Med; 2006 Jan; 31(1):44-5. PubMed ID: 16374127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant Peripheral Nerve Sheath Tumor With Bilateral Adrenal Metastases: Role of 18F-FDG PET/CT in Response Assessment to Tyrosine Kinase Inhibitor and Liposomal Doxorubicin.
    Tripathy S; Passah A; Singhal A; Prashanth A; Kumar R
    Clin Nucl Med; 2019 Jun; 44(6):494-495. PubMed ID: 30889004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.
    Urban T; Lim R; Merker VL; Muzikansky A; Harris GJ; Kassarjian A; Bredella MA; Plotkin SR
    Clin Nucl Med; 2014 May; 39(5):e301-7. PubMed ID: 24152623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.
    Friedrich RE; Gawad K; Derlin T; Zustin J; Hagel C
    Anticancer Res; 2012 Oct; 32(10):4547-51. PubMed ID: 23060584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiological findings of malignant peripheral nerve sheath tumor: reports of six cases and review of literature.
    Yu YH; Wu JT; Ye J; Chen MX
    World J Surg Oncol; 2016 May; 14():142. PubMed ID: 27159980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of von Recklinghausen's disease with coincident malignant peripheral nerve sheath tumor and gastrointestinal stromal tumor.
    Otomi Y; Otsuka H; Morita N; Terazawa K; Harada M; Nishitani H
    J Med Invest; 2009 Feb; 56(1-2):76-9. PubMed ID: 19262018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report: Metastasis of a Trigeminal Malignant Peripheral Nerve Sheath Tumor to the Corpus Callosum.
    Shutran M; Mosbach D; Tataryn Z; Arkun K; Wu JK
    Neurosurgery; 2019 Jan; 84(1):E63-E67. PubMed ID: 29518229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT.
    Salamon J; Papp L; Tóth Z; Laqmani A; Apostolova I; Adam G; Mautner VF; Derlin T
    PLoS One; 2015; 10(12):e0143305. PubMed ID: 26625155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review.
    Luna R; Fayad LM; Rodriguez FJ; Ahlawat S
    Skeletal Radiol; 2021 Jan; 50(1):201-215. PubMed ID: 32699955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1].
    Bensaid B; Giammarile F; Mognetti T; Galoisy-Guibal L; Pinson S; Drouet A; Combemale P
    Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):735-41. PubMed ID: 17978710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
    Drieskens O; Stroobants S; Gysen M; Vandenbosch G; Mortelmans L; Vergote I
    Gynecol Obstet Invest; 2003; 55(3):130-4. PubMed ID: 12865590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].
    Malerba M; Garofalo A
    Tumori; 2003; 89(4 Suppl):246-50. PubMed ID: 12903608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F-fluoro-2-deoxyglucose-positron emission tomography in the evaluation of nonseminomatous germ cell tumours at relapse.
    Sanchez D; Zudaire JJ; Fernandez JM; Lopez J; Arocena J; Sanz G; Gimenez M; Rosell D; Robles JE; Berian JM
    BJU Int; 2002 Jun; 89(9):912-6. PubMed ID: 12010239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
    Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
    J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
    Fricke E; Machtens S; Hofmann M; van den Hoff J; Bergh S; Brunkhorst T; Meyer GJ; Karstens JH; Knapp WH; Boerner AR
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [18-FDG-PET in a case of recurrent malignant schwannoma].
    Santaella Y; Borrego I; López J; Ortiz MJ; Vázquez R
    Rev Esp Med Nucl; 2005; 24(2):127-30. PubMed ID: 15745683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.